Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer

Background: Magnetic resonance imaging (MRI)-based risk calculators (MRI-RCs) individualise the likelihood of clinically significant prostate cancer (csPCa) and improve candidate selection for prostate biopsy beyond the Prostate Imaging Reporting and Data System (PI-RADS). Objective: To compare the...

Full description

Bibliographic Details
Main Authors:	Juan Morote, Ángel Borque-Fernando, Marina Triquell, Miriam Campistol, Pol Servian, José M. Abascal, Jacques Planas, Olga Méndez, Luis M. Esteban, Enrique Trilla
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	European Urology Open Science
Subjects:	Prostate cancer Clinically significant Early detection Magnetic resonance imaging Predictive model Risk calculator
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168323001969

Similar Items

A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand
by: Juan Morote, et al.
Published: (2022-10-01)

The Barcelona Predictive Model of Clinically Significant Prostate Cancer
by: Juan Morote, et al.
Published: (2022-03-01)

Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate‐specific antigen, digital rectal examination and the prostate‐specific antigen density based on digital rectal prostate volume category
by: Juan Morote, et al.
Published: (2023-05-01)

A risk‐organised model for clinically significant prostate cancer early detection
by: Juan Morote, et al.
Published: (2023-07-01)

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
by: Juan Morote, et al.
Published: (2022-05-01)

Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review
by: Marina Triquell, et al.
Published: (2022-09-01)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
by: Miriam Campistol, et al.
Published: (2022-05-01)

Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer
by: Juan Morote, et al.
Published: (2024-01-01)

The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
by: Juan Morote, et al.
Published: (2022-04-01)

Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center
by: Philipp Krausewitz, et al.
Published: (2024-03-01)

A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic Biopsies
by: Juan Morote, et al.
Published: (2023-09-01)

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
by: Ugo Giovanni Falagario, et al.
Published: (2021-01-01)

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator
by: Sneha Parekh, et al.
Published: (2022-07-01)

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
by: Jan Chandra Engel, et al.
Published: (2022-07-01)

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
by: Juan Morote, et al.
Published: (2022-04-01)

Definition of Castrate Resistant Prostate Cancer: New Insights
by: Juan Morote, et al.
Published: (2022-03-01)

Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy
by: Marina Triquell, et al.
Published: (2022-08-01)

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy
by: Juan Morote, et al.
Published: (2022-08-01)

PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL
by: Christiano Tansol, et al.
Published: (2017-07-01)

Importance of Malignant Core Length in the Detection of Clinically Significant Prostate Cancer in Transrectal Prostate Biopsies
by: Gökçe Dündar, et al.
Published: (2023-06-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

Radiomic Machine-Learning Analysis of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: New Combination of Textural and Clinical Features
by: Francesco Prata, et al.
Published: (2023-02-01)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan Profiling
by: Sarah Gilgunn, et al.
Published: (2020-12-01)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
by: Shih-Ting Chiu, et al.
Published: (2021-11-01)

The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate Volume
by: Juan Morote, et al.
Published: (2024-04-01)

MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
by: Furat Abd Ali, et al.
Published: (2023-08-01)

The Role of Perineural Invasion in Prostate Cancer and Its Prognostic Significance
by: Yuequn Niu, et al.
Published: (2022-08-01)

Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance
by: Xiao Liu, et al.
Published: (2021-12-01)

Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review
by: Adriana Aguilar, et al.
Published: (2023-07-01)

Phi-based risk calculators performed better in the prediction of prostate cancer in the Chinese population
by: Yi-Shuo Wu, et al.
Published: (2019-01-01)

Treatment Changes Clinical Significance Method: Properties, Calculation Method, Decision Making and Limitations
by: M.A Asghari Moghaddam, et al.
Published: (2014-09-01)

PI‐RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
by: Andrés Camacho, et al.
Published: (2023-07-01)

Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection
by: Igor Sorokin, et al.
Published: (2015-01-01)

The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study
by: Yi-Shuo Wu, et al.
Published: (2016-01-01)

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram
by: Guodong Jing, et al.
Published: (2022-07-01)

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study
by: Yin Lei, et al.
Published: (2022-09-01)

Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
by: Tianping Li, et al.
Published: (2022-01-01)

A PI-RADS-Based New Nomogram for Predicting Clinically Significant Prostate Cancer: A Cohort Study
by: Zhang Y, et al.
Published: (2020-05-01)

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis
by: Huang M, et al.
Published: (2018-08-01)

Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer
by: Lin Li, et al.
Published: (2023-01-01)